Stryker Corporation
SYKLast close · Oct 16, 2026294.66+1.43 (+0.49%)
Market cap$113.0B
11 firms' latest targets, last 90 days: median $370.00 ($310.00–$420.00), 26% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-10-12 | BTIG | $316.00 | ▼ 12% | +7% |
| 2026-10-06 | Barclays | $375.00 | ▼ 5% | +27% |
| 2026-10-06 | Truist | $310.00 | ▼ 6% | +5% |
| 2026-09-30 | Stifel | $330.00 | — | +12% |
| 2026-09-18 | Canaccord Genuity | $385.00 | — | +31% |
| 2026-09-09 | BMO Capital | $317.00 | ▼ 14% | +8% |
| 2026-09-09 | Wells Fargo | $348.00 | — | +18% |
| 2026-07-31 | RBC Capital | $420.00 | ▼ 3% | +43% |
| 2026-07-31 | Raymond James | $370.00 | ▼ 11% | +26% |
| 2026-07-31 | Piper Sandler | $390.00 | — | +32% |
| 2026-07-31 | Wolfe Research | $375.00 | — | +27% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2023reported | $20.5B | +11% | $8.25 | +34% | est. $20.3B+1% | est. $10.41 | 19 |
| 2024reported | $22.6B | +10% | $7.76 | -6% | est. $22.5B+0% | est. $12.05 | 19 |
| 2025reported | $25.1B | +11% | $8.40 | +8% | est. $25.1B+0% | est. $13.56 | 18 |
| 2026 | $27.2B | +8% | $14.96 | +10% | $26.9B–$27.4B | $14.90–$15.06 | 20 |
| 2027 | $29.5B | +9% | $16.69 | +12% | $28.7B–$29.9B | $16.13–$17.16 | 20 |
| 2028 | $31.9B | +8% | $18.61 | +11% | $31.2B–$32.5B | $17.42–$19.41 | 22 |
| 2029 | $34.8B | +9% | $20.75 | +12% | $34.3B–$35.8B | $20.36–$21.57 | 14 |
| 2030 | $37.6B | +8% | $23.05 | +11% | $37.1B–$38.8B | $22.61–$23.95 | 11 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.